Trial Profile

Cost-Effectiveness of Prophylaxis with Anti-Inhibitor Complex Concentrate in Patients with Hemophilia A and Inhibitors: the Pro-FEIBA Study

Status: Completed

Phase of Trial: Phase IV

Latest Information Update: 10 Sep 2015

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Factor VIII inhibitor bypassing fraction (Primary)
Indications Haemophilia A
Focus Therapeutic Use
Acronyms PRO-FEIBA

Most Recent Events

07 Nov 2012 Results of a quality-of-life analysis presented at the 15th Annual European Conference of the International Society for Pharmacoeconomics and Outcomes Research.
07 Nov 2012 Results of a cost-effectiveness analysis presented at the 15th Annual European Conference of the International Society for Pharmacoeconomics and Outcomes Research.
21 Dec 2011 New trial record

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com